Annual report pursuant to Section 13 and 15(d)

Segment Reporting

v3.21.1
Segment Reporting
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Segment Reporting

NOTE 23 - SEGMENT REPORTING

 

A. General information

 

Commencing 2020, the operations of the Company are conducted through three different core activities: Breast Cancer Test (TM-B1, TM-B2), Alzheimer and COVID-19 testing, each of which are operating segments. These activities also represent the reportable segments of the Group.

 

The reportable segments are viewed and evaluated separately by Company’s management, since the marketing strategies, processes and expected long term financial performances of the segments are different.

 

B. Information about reported segment profit or loss and assets

 

   

Breast

Cancer Test

    

 

Alzheimer

     COVID-19 testing    

 

Total

  
                         
Year ended December 31, 2020                                
Revenues     -       -       5,207       5,207  
Operating loss     (4,943 )     (8,327 )     (991 )     (14,081 )
Unallocated amounts:                                
Financing expenses, net                             (14,(312  
Share in losses of affiliated companies accounted for under equity method, net                             (1,200 )
Net loss     (4,943 )     (8,327 )     (991 )     (29,773 )
Total assets     1,554       -       4,455       6,009  
Other significant items:                                
Total expenditures for assets of reportable segments     24       -       2,006       2,030  
Total depreciation for reportable segments     (28 )     -       (68 )     (96 )

 

The evaluation of performance is based on the operating income or loss of each of the three reportable segments.

 

Accounting policies of the segments are the same as those described in the accounting policies applied in the consolidated financial statements.

 

Due to the reportable segments’ nature, there have been no inter-segment sales or transfers during the reported periods.

 

Financing expenses, net and the share of the Company in losses of affiliated companies were not allocated to the reportable segments, since these items are carried and evaluated on the enterprise level.

 

Management has determined that none of the equity method investees is eligible to be considered as reportable segment as they do not meet the criteria in ASC Topic 280-10-50 (or they did not commence their operations).

 

C. Revenues by geographic region are as follows:

 

   

Year ended

December 31

  
    2020     2019  
             
Israel   $ -     $ -  
United States     5,207       -  
    $ 5,207     $ -  

 

Total revenues by geographic region are based upon the geographic location of the customer.

D. Property and equipment, net, by geographic areas:

 

   

As of

December 31,

  
    2020     2019  
Israel   $ 61     $ 65  
United States     1,938       -  
    $ 1,999     $ 65  

 

Property and equipment are attributed to the geographic area in which they are located or originated, as applicable.

 

E. Major customers

 

During the year ended December 31, 2019, there were no sales activities. During the year ended December 31, 2020, the Company had one costumer which accounted for 56.64% of the Company’s revenues.